• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
MicroRNA Profiling of Salivary Duct Carcinoma Versus Her2/Neu Overexpressing Breast Carcinoma Identify miR-10a as a Putative Breast Related Oncogene.唾液腺导管癌与HER2/neu过表达乳腺癌的MicroRNA谱分析确定miR-10a为一种假定的乳腺相关癌基因。
Head Neck Pathol. 2019 Sep;13(3):344-354. doi: 10.1007/s12105-018-0971-x. Epub 2018 Sep 26.
2
Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.原位、浸润性和淋巴管血管侵犯乳腺癌之间差异 microRNA 表达谱分析:一项初步研究。
Clin Exp Metastasis. 2018 Feb;35(1-2):3-13. doi: 10.1007/s10585-017-9868-4. Epub 2017 Dec 6.
3
Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations.149 例涎腺导管癌、多形性腺癌癌变和非特异性腺癌的分析揭示了可操作的基因组改变。
Clin Cancer Res. 2016 Dec 15;22(24):6061-6068. doi: 10.1158/1078-0432.CCR-15-2568. Epub 2016 Jun 22.
4
miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast.miR-145、miR-205 和 miR-451:参与乳腺原位癌向浸润性癌进展的潜在肿瘤抑制因子。
Breast Cancer. 2022 Sep;29(5):814-824. doi: 10.1007/s12282-022-01359-9. Epub 2022 Apr 22.
5
Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.涎腺导管癌的综合分子特征揭示了可操作的靶点及与乳腺大汗腺癌的相似性。
Clin Cancer Res. 2016 Sep 15;22(18):4623-33. doi: 10.1158/1078-0432.CCR-16-0637. Epub 2016 Apr 21.
6
An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.唾液腺癌中 PLAG1 和 HMGA2 重排的分析及前病变作用的研究。
Histopathology. 2013 Aug;63(2):250-62. doi: 10.1111/his.12152. Epub 2013 Jun 6.
7
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment.检测唾液腺癌中新的可操作遗传改变有助于指导患者治疗。
Clin Cancer Res. 2013 Jan 15;19(2):480-90. doi: 10.1158/1078-0432.CCR-12-1842. Epub 2012 Nov 27.
8
Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy.唾液腺癌中频繁的 PTEN 缺失和差异的 HER2/PI3K 信号通路改变:对靶向治疗的影响。
Cancer. 2018 Sep 15;124(18):3693-3705. doi: 10.1002/cncr.31600. Epub 2018 Oct 5.
9
MicroRNA Profiling and Target Genes Related to Metastasis of Salivary Adenoid Cystic Carcinoma.与涎腺腺样囊性癌转移相关的微小RNA谱及靶基因
Anticancer Res. 2017 Jul;37(7):3473-3481. doi: 10.21873/anticanres.11715.
10
ALK Rearrangements Characterize 2 Distinct Types of Salivary Gland Carcinomas: Clinicopathologic and Molecular Analysis of 4 Cases and Literature Review.ALK 重排特征化 2 种不同类型的唾液腺癌:4 例临床病理和分子分析及文献复习。
Am J Surg Pathol. 2021 Sep 1;45(9):1166-1178. doi: 10.1097/PAS.0000000000001698.

引用本文的文献

1
Dynamic Role of miRNAs in Salivary Gland Carcinomas: From Biomarkers to Therapeutic Targets.miRNAs 在唾液腺癌中的动态作用:从生物标志物到治疗靶点。
Head Neck Pathol. 2024 Feb 23;18(1):12. doi: 10.1007/s12105-023-01603-4.
2
miRNAs in Cancer (Review of Literature).miRNAs 在癌症中的作用(文献综述)。
Int J Mol Sci. 2022 Mar 3;23(5):2805. doi: 10.3390/ijms23052805.
3
The emerging role of miR-10 family in gastric cancer.miR-10 家族在胃癌中的新兴作用。
Cell Cycle. 2021 Aug;20(15):1468-1476. doi: 10.1080/15384101.2021.1949840. Epub 2021 Jul 7.
4
Retinoic Acid Downregulates HSPB8 Gene Expression in Human Breast Cancer Cells MCF-7.视黄酸下调人乳腺癌细胞MCF-7中HSPB8基因的表达。
Front Oncol. 2021 May 31;11:652085. doi: 10.3389/fonc.2021.652085. eCollection 2021.
5
Folate pathways mediating the effects of ethanol in tumorigenesis.叶酸代谢途径介导乙醇在肿瘤发生中的作用。
Chem Biol Interact. 2020 Jun 1;324:109091. doi: 10.1016/j.cbi.2020.109091. Epub 2020 Apr 10.
6
Answer to Controversy: miR-10a Replacement Approaches Do Not Offer Protection against Chemotherapy-Induced Gonadotoxicity in Mouse Model.争议解答:miR-10a 替代方法不能为小鼠模型提供对抗化疗诱导的性腺毒性的保护。
Int J Mol Sci. 2019 Oct 8;20(19):4958. doi: 10.3390/ijms20194958.

本文引用的文献

1
MicroRNA-30c suppressed giant-cell tumor of bone cell metastasis and growth via targeting HOXA1.微小 RNA-30c 通过靶向 HOXA1 抑制骨巨细胞瘤细胞转移和生长。
Eur Rev Med Pharmacol Sci. 2017 Nov;21(21):4819-4827.
2
MicroRNA-30e reduces cell growth and enhances drug sensitivity to gefitinib in lung carcinoma.微小RNA-30e可抑制肺癌细胞生长并增强对吉非替尼的药物敏感性。
Oncotarget. 2017 Jan 17;8(3):4572-4581. doi: 10.18632/oncotarget.13944.
3
Emerging role of microRNA-21 in cancer.微小RNA-21在癌症中的新兴作用。
Biomed Rep. 2016 Oct;5(4):395-402. doi: 10.3892/br.2016.747. Epub 2016 Aug 26.
4
The Role of Mir-148a in Cancer.微小RNA-148a在癌症中的作用。
J Cancer. 2016 Jun 21;7(10):1233-41. doi: 10.7150/jca.14616. eCollection 2016.
5
Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.涎腺导管癌的综合分子特征揭示了可操作的靶点及与乳腺大汗腺癌的相似性。
Clin Cancer Res. 2016 Sep 15;22(18):4623-33. doi: 10.1158/1078-0432.CCR-16-0637. Epub 2016 Apr 21.
6
MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.微小RNA-99a通过调控乳腺癌细胞中的HOXA1来抑制肿瘤侵袭性表型。
Oncotarget. 2015 Oct 20;6(32):32737-47. doi: 10.18632/oncotarget.5355.
7
miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.miR-21与miR-145在结肠癌干细胞调控中的协同作用。
Mol Cancer. 2015 May 1;14:98. doi: 10.1186/s12943-015-0372-7.
8
Molecular characterization of apocrine salivary duct carcinoma.大汗腺癌的分子特征。
Am J Surg Pathol. 2015 Jun;39(6):744-52. doi: 10.1097/PAS.0000000000000410.
9
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.高通量分析鉴定出涎腺导管癌中具有临床可操作性的突变。
J Transl Med. 2014 Oct 25;12:299. doi: 10.1186/s12967-014-0299-6.
10
Regulatory MiR-148a-ACVR1/BMP circuit defines a cancer stem cell-like aggressive subtype of hepatocellular carcinoma.调控性微小RNA-148a-激活素受体1/骨形态发生蛋白信号通路定义了一种肝癌干细胞样侵袭性亚型。
Hepatology. 2015 Feb;61(2):574-84. doi: 10.1002/hep.27543.

唾液腺导管癌与HER2/neu过表达乳腺癌的MicroRNA谱分析确定miR-10a为一种假定的乳腺相关癌基因。

MicroRNA Profiling of Salivary Duct Carcinoma Versus Her2/Neu Overexpressing Breast Carcinoma Identify miR-10a as a Putative Breast Related Oncogene.

作者信息

Balatti Veronica, Oghumu Steve, Bottoni Arianna, Maharry Kati, Cascione Luciano, Fadda Paolo, Parwani Anil, Croce Carlo, Iwenofu O Hans

机构信息

Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, USA.

Department of Pathology and Laboratory Medicine, The Ohio State University, Columbus, USA.

出版信息

Head Neck Pathol. 2019 Sep;13(3):344-354. doi: 10.1007/s12105-018-0971-x. Epub 2018 Sep 26.

DOI:10.1007/s12105-018-0971-x
PMID:30259272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6684709/
Abstract

Salivary duct carcinomas (SDC) and Her2/Neu3-overexpressing invasive breast carcinomas (HNPIBC/IBC) are histologically indistinguishable. We investigated whether common histopathologic and immunophenotypic features of SDC and IBC are mirrored by a similar microRNA (miRNA) profile. MiRNA profiling of 5 SDCs, 6 IBCs Her2/Neu3+, and 5 high-grade ductal breast carcinoma in situ (DCIS) was performed by NanoString platform. Selected miRNAs and HOXA1 gene were validated by RT-PCR. We observed similar miRNA expression profiles between IBC and SDC with the exception of 2 miRNAs, miR-10a and miR-142-3p, which were higher in IBC tumors. DCIS tumors displayed increased expression of miR-10a, miR-99a, miR-331-3p and miR-335, and decreased expression of miR-15a, miR-16 and miR-19b compared to SDC. The normal salivary gland and breast tissues also showed similar expression profiles. Interestingly, miR-10a was selectively increased in both IBC and normal breast tissue compared to SDC and normal salivary gland tissue. Moreover, our NanoString and RT-PCR data confirmed that miR-10a was upregulated in IBC and DCIS compared to SDC. Finally, we show downregulation of HOXA1, a miR-10 target, in IBC tumors compared to normal breast tissue. Taken together, our data demonstrates that, based on miRNA profiling, SDC is closely related to HNPIBC. Our results also suggest that miR-10a is differentially expressed in IBC compared to SDC and may have potential utility as a diagnostic biomarker in synchronous or metachronous malignant epithelial malignancies involving both organs. In addition, miR-10a could be playing an important role as a mammary-specific oncogene, involved in breast cancer initiation (DCIS) and progression (IBC), through mechanisms that include modulation of HOXA1 gene expression.

摘要

涎腺导管癌(SDC)与过表达人表皮生长因子受体2/神经氨酸酶3(Her2/Neu3)的浸润性乳腺癌(HNPIBC/IBC)在组织学上难以区分。我们研究了SDC和IBC常见的组织病理学和免疫表型特征是否反映在相似的微小RNA(miRNA)谱中。通过NanoString平台对5例SDC、6例Her2/Neu3阳性的IBC和5例高级别导管原位癌(DCIS)进行了miRNA谱分析。通过逆转录-聚合酶链反应(RT-PCR)对选定的miRNA和HOXA1基因进行了验证。我们观察到IBC和SDC之间的miRNA表达谱相似,但有2种miRNA(miR-10a和miR-142-3p)除外,它们在IBC肿瘤中表达较高。与SDC相比,DCIS肿瘤中miR-10a、miR-99a、miR-331-3p和miR-335的表达增加,而miR-15a、miR-16和miR-19b的表达降低。正常涎腺组织和乳腺组织也显示出相似的表达谱。有趣的是,与SDC和正常涎腺组织相比,miR-10a在IBC和正常乳腺组织中均选择性增加。此外,我们的NanoString和RT-PCR数据证实,与SDC相比,miR-10a在IBC和DCIS中上调。最后,我们发现与正常乳腺组织相比,IBC肿瘤中miR-10的靶基因HOXA1表达下调。综上所述,我们的数据表明,基于miRNA谱分析,SDC与HNPIBC密切相关。我们的结果还表明,与SDC相比,miR-10a在IBC中差异表达,可能作为涉及两个器官的同步或异时性恶性上皮性肿瘤的诊断生物标志物具有潜在应用价值。此外,miR-10a可能作为乳腺特异性癌基因发挥重要作用,通过包括调节HOXA1基因表达在内的机制参与乳腺癌的起始(DCIS)和进展(IBC)。